Open randomized study for the evaluation of activities of AS/AQ (co-packaged and co-formulated) versus AL on asexual & sexual paraistes in childre

Not Applicable

• Conditions: Malaria; Paediatrics

• Registration Number: PACTR201508001188143
• Lead Sponsor: Swiss Pharma Nigeria Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-03
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

boby weight at least 5 kg
History of fever
microscopically confirmed pure Plasmodium falciparum infection >/= 2000/uL
Presence or history of fever (temp. >37.4)
written informed consent

Exclusion Criteria

severe malaria
History of alergy to study drugs
Presence of concomitant illness
Signs of severe malnutrition
Patient with history of hepatic, cardiac or renal disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
28-42 days PCR-corrected cure rates

Secondary Outcome Measures

Name	Time	Method
Proportion of patients with parasitaemia or fever;Prevalence and intesities of gametocytaemia